Application of Vibration Wave Therapy to the Children Suffering From Cerebral Palsy and Tongue Spastic Dysarthria

June 13, 2020 updated by: Aliya Ashraf Khan, National University of Science and Technology, Pakistan

Application of Vibration Wave Therapy to the Speech of Children Suffering From Cerebral Palsy and Dysarthria Using Neuro Transmission Cognitive Theory: Single Group Experimental Study

Vibration therapy is the widely used in many neurological disorders for different type of problems. Recently, it is being used by researchers for the betterment of motor disorders and muscle movements of the cerebral palsy patients and significant results are obtained. Investigators are conducting this research to explore that whether this therapy can have some effect on the Spastic Tongue Dysarthria of the Cerebral Palsy patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study is going to be conducted in collaboration with Shahbaz Khalid Ranjha , Speech Language Pathologist, Family Health Hospital Islamabad who is the main person for the idea of the study and National University of Science & Technology. This study is funded by Higher Education Commission of Pakistan. Recruitment and Intervention Work will be carried out in Family Health Hospital. Special device is being designed for transmission of Vibration waves in Lab of the university. The device is capable to transmit vibration waves to the patient. Urdu language phonological and articulation test(TAAPU) will be used for assessment as it is specially designed for Urdu language population which will be the main focus. Investigators have defined speech parameters for analysis which will be collected before application of intervention, after 3 months and then at the end of the study. Parents assessment will be collected and noted through out the intervention.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Federal
      • Islamabad, Federal, Pakistan, 42200
        • Family Health Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children having dysarthria due to cerebral Palsy
  • Dysarthria due to damage in motor speech area/ broca area.
  • Children having type Spastic Dysarthria

Exclusion Criteria:

Children diagnosed with following are excluded from our study

  • Any speech disorders
  • hearing impairments
  • cleft palate
  • tongue tie.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: spastic Tongue Dysarthria
The purpose of gadget is to transmit the mechanical vibration waves to the brain of the subjects.
The concept is to apply vibro tactile gadget to different nerve points which when applied transmit waves to the focused parts of brain which will result in blood flow and activation of dead cells. As a result some disabled part of the body because of those dead cells can show improvement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child Historical Treatment Measurement
Time Frame: At Enrollment
Socio demographic and Health related data is collected so that that efficacy of treatment under study can be calculated w.r.t pre treatment assessments
At Enrollment
Change in phonological disorders using TAAPU Test for assessment of articulation and phonology in urdu language
Time Frame: At month 0, At month 03 and at month 06
Scores for fronting, stopping, phonological disorders, final consonant deletion, Nasal assimilation and de-palatalization is calculated pre and post assessment through TAAPU(Test for assessment of articulation and phonology in urdu language).
At month 0, At month 03 and at month 06
Parent Assessment Checklist
Time Frame: At month 0
A questionnaire is prepared for the child assessment by the parent.
At month 0
Parent Assessment Checklist
Time Frame: At month 3
A questionnaire is prepared for the child assessment by the parent.
At month 3
Parent Assessment Checklist
Time Frame: At month 6
A questionnaire is prepared for the child assessment by the parent.
At month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parent Assessment Checklist
Time Frame: At month 01
A questionnaire is prepared for the child assessment by the parent.
At month 01
Parent Assessment Checklist
Time Frame: At month 02
A questionnaire is prepared for the child assessment by the parent.
At month 02
Parent Assessment Checklist
Time Frame: At month 04
A questionnaire is prepared for the child assessment by the parent.
At month 04
Parent Assessment Checklist
Time Frame: At month 05
A questionnaire is prepared for the child assessment by the parent.
At month 05
Change in phonological disorders using TAAPU Test for assessment of articulation and phonology in urdu language
Time Frame: At month 01 and At month 02
Scores for fronting, stopping, phonological disorders, final consonant deletion, Nasal assimilation and de-palatalization is calculated pre and post assessment through TAAPU(Test for assessment of articulation and phonology in urdu language).
At month 01 and At month 02

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Shahbaz K Ranjha, MPhil, Family Health Hospital Islamabad
  • Principal Investigator: Aliya A Khan, MS, National University of Science & Technology
  • Study Chair: Mohammad U Akram, Phd, National University of Science & Technology
  • Principal Investigator: Madeeha Nissar, MSc, Isra University islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2019

Primary Completion (Actual)

May 12, 2020

Study Completion (Actual)

June 14, 2020

Study Registration Dates

First Submitted

January 1, 2020

First Submitted That Met QC Criteria

January 6, 2020

First Posted (Actual)

January 9, 2020

Study Record Updates

Last Update Posted (Actual)

June 16, 2020

Last Update Submitted That Met QC Criteria

June 13, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

we will show the data to other researchers once study is completed and results are published.

IPD Sharing Time Frame

After the publication of the results data will be available for researchers who can benefit from it whenever they want.

IPD Sharing Access Criteria

Data will be shared to those researchers who want to continue research in the area

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Vibro Tactile Gadget

3
Subscribe